Details for 2018161509
Up to date per 03.04.2026
Actions
Details for 2018161509
Granted/Registered
European Patent
01.08.2018 A
30.06.2021 B1
28.07.2009
US
22919509 P
10.02.2010
US
30304410 P
25.03.2010
US
31751310 P
11.05.2010
US
33337210 P
28.06.2010
US
35933810 P
A61K 38/47 20060101AFI20180618BHEP
Owner
Takeda Pharmaceutical Company Limited1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, OsakaJP
Representative
Representative
Haffner und Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT
Inventor
DANIEL, Peter, F.100 North Avenue Natick MA Massachusetts 01760US
HEARTLEIN, Michael, W.167 Reed Farm Road Boxborough MA Massachusetts 01719US
Information about Fees